These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8380950)

  • 1. High plasma concentrations of endothelin-like immunoreactivities in patients with hepatocellular carcinoma.
    Nakamuta M; Ohashi M; Tabata S; Tanabe Y; Goto K; Naruse M; Naruse K; Hiroshige K; Nawata H
    Am J Gastroenterol; 1993 Feb; 88(2):248-52. PubMed ID: 8380950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and secretion of endothelin by hepatocellular carcinoma.
    Ishibashi M; Fujita M; Nagai K; Kako M; Furue H; Haku E; Osamura Y; Yamaji T
    J Clin Endocrinol Metab; 1993 Feb; 76(2):378-83. PubMed ID: 7679399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma endothelin-1 concentrations are elevated in acute hepatitis and liver cirrhosis but not in chronic hepatitis.
    Uchida Y; Watanabe M
    Gastroenterol Jpn; 1993 Oct; 28(5):666-72. PubMed ID: 8224617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High plasma concentrations of nitrite/nitrate in patients with hepatocellular carcinoma.
    Moriyama A; Masumoto A; Nanri H; Tabaru A; Unoki H; Imoto I; Ikeda M; Otsuki M
    Am J Gastroenterol; 1997 Sep; 92(9):1520-3. PubMed ID: 9317076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma.
    Hayasaka A; Suzuki N; Fujimoto N; Iwama S; Fukuyama E; Kanda Y; Saisho H
    Hepatology; 1996 Nov; 24(5):1058-62. PubMed ID: 8903375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
    PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-1 expression by human hepatocellular carcinoma.
    Kar S; Yousem SA; Carr BI
    Biochem Biophys Res Commun; 1995 Nov; 216(2):514-9. PubMed ID: 7488141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of plasma endothelin-1 in patients with chronic liver disease.
    Matsumoto H; Uemasu J; Kitano M; Kawasaki H
    Dig Dis Sci; 1994 Dec; 39(12):2665-70. PubMed ID: 7995194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
    Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial protein C receptor plasma levels increase in chronic liver disease, while thrombomodulin plasma levels increase only in hepatocellular carcinoma.
    Biguzzi E; Franchi F; Bucciarelli P; Colombo M; Romeo R
    Thromb Res; 2007; 120(2):289-93. PubMed ID: 17049585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma.
    Waidmann O; Köberle V; Bettinger D; Trojan J; Zeuzem S; Schultheiß M; Kronenberger B; Piiper A
    J Hepatol; 2013 Oct; 59(4):769-79. PubMed ID: 23792028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma.
    Sacco R; Leuci D; Tortorella C; Fiore G; Marinosci F; Schiraldi O; Antonaci S
    Cytokine; 2000 Jun; 12(6):811-4. PubMed ID: 10843770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma proteasome level is a reliable early marker of malignant transformation of liver cirrhosis.
    Henry L; Lavabre-Bertrand T; Vercambre L; Ramos J; Carillo S; Guiraud I; Pouderoux P; Bismuth M; Valats JC; Demattei C; Duny Y; Chaze I; Funakoshi N; Bureau JP; Daurès JP; Blanc P
    Gut; 2009 Jun; 58(6):833-8. PubMed ID: 19201777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.
    Giannini EG; Marenco S; Borgonovo G; Savarino V; Farinati F; Del Poggio P; Rapaccini GL; Anna Di Nolfo M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
    Hepatology; 2012 Oct; 56(4):1371-9. PubMed ID: 22535689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases.
    Shiota G; Umeki K; Okano J; Kawasaki H
    J Med; 1995; 26(5-6):295-308. PubMed ID: 8721905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma abnormal prothrombin levels in patients with small hepatocellular carcinoma.
    Tanabe Y; Ohnishi K; Nomura F; Iida S
    Am J Gastroenterol; 1988 Dec; 83(12):1386-9. PubMed ID: 2461655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
    Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y
    World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of circulating activin-A as a serum marker of hepatocellular carcinoma.
    Pirisi M; Fabris C; Luisi S; Santuz M; Toniutto P; Vitulli D; Federico E; Del Forno M; Mattiuzzo M; Branca B; Petraglia F
    Cancer Detect Prev; 2000; 24(2):150-5. PubMed ID: 10917135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
    Cui R; Wang B; Ding H; Shen H; Li Y; Chen X
    Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.